RECRUITING

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project seeks to learn more about the effects of cannabis use on the endocannabinoid system and endogenous opioid systems in adolescents to address a fundamental gap in knowledge and identify biomarkers that may help distinguish youth who relapse from youth who remain sober.

Official Title

Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents

Quick Facts

Study Start:2022-10-13

Study Completion:2024-12

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05396638

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years to 25 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD, ADULT

Inclusion Criteria	Exclusion Criteria
1. 14 to 25 years of age. 2. Use cannabis at least twice a week for the past month.	1. Refusal of valid written consent, 2. Current psychosis, 3. Obvious intoxication, 4. Current risk of suicide, 5. Violence sufficiently great to interfere with evaluation or to endanger evaluators, 6. Obvious intellectual deficiency as noted during the informed consent process, or inability of patient or family to comply with the study protocol. 7. Use of other illicit drugs in the past 90 days by self-report or detected by urine drug test. 8. Use of opioid medications for medical or recreational purposes currently or within the past 90 days. 9. Does not have access to an Internet connected devise or cannot use Zoom.

Inclusion Criteria

Exclusion Criteria

1. 14 to 25 years of age.
2. Use cannabis at least twice a week for the past month.

1. Refusal of valid written consent,
2. Current psychosis,
3. Obvious intoxication,
4. Current risk of suicide,
5. Violence sufficiently great to interfere with evaluation or to endanger evaluators,
6. Obvious intellectual deficiency as noted during the informed consent process, or inability of patient or family to comply with the study protocol.
7. Use of other illicit drugs in the past 90 days by self-report or detected by urine drug test.
8. Use of opioid medications for medical or recreational purposes currently or within the past 90 days.
9. Does not have access to an Internet connected devise or cannot use Zoom.

Contacts and Locations

Study Contact

Jesse Hinckley, MD, PhD

CONTACT

303-724-3090

jesse.hinckley@cuanschutz.edu

Kristen Raymond, BA

CONTACT

303-724-3196

kristen.raymond@cuanschutz.edu

Study Locations (Sites)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045

United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-13

Study Completion Date2024-12

Study Record Updates

Study Start Date2022-10-13

Study Completion Date2024-12

Terms related to this study

Additional Relevant MeSH Terms

Cannabis Use